Literature DB >> 23887161

Spindle cell oncocytomas and granular cell tumors of the pituitary are variants of pituicytoma.

Ozgur Mete1, Maria Beatriz Lopes, Sylvia L Asa.   

Abstract

Pituicytomas are neoplasms that arise from pituicytes, which are specialized glia of the posterior pituitary. Pituicytes have 5 ultrastructural variants: light, dark, granular, ependymal, and oncocytic. Granular cell tumors of the pituitary gland are thought to arise from granular pituicytes. Spindle cell oncocytomas are considered to arise from folliculostellate cells, which are sustentacular cells of the adenohypophysis. Recent data suggest that, whereas pituicytes and all 3 tumor types are positive for TTF-1, folliculostellate cells are negative for TTF-1. We investigated 7 spindle cell oncocytomas, 4 pituicytomas, and 3 granular cell tumors for their genetic (BRAF(V600E) mutation and BRAF-KIAA fusion), immunohistochemical (GFAP, vimentin, S100 protein, olig2, IDH1-R132H, NF, galectin-3, chromogranin-A, CD56, EMA, CAM5.2, CD68, TTF-1, and bcl-2), and ultrastructural features to refine their classification. All tumors had nuclear positivity for TTF-1 and were negative for CAM5.2, chromogranin-A, and NF. GFAP, vimentin, S100, galectin-3, EMA, and CD68 were variably positive in the majority of the 3 tumor groups. Olig2 was only positive in 1 pituicytoma. Whereas granular cell tumors were negative for bcl-2 and CD56, pituicytomas and spindle cell oncocytomas showed variable positivity. All tumors were negative with the IDH1-R132H mutation-specific antibody, and none had evidence of BRAF alterations (BRAF(V600E) mutation and BRAF-KIAA fusion). Diffuse TTF-1 expression in nontumorous pituicytes, pituicytomas, spindle cell oncocytomas, and granular cell tumors indicates a common pituicyte lineage. The ultrastructural variants of pituicytes are reflected in these 3 morphologic variants of tumors arising from these cells. We propose the terminology "oncocytic pituicytomas" and "granular cell pituicytomas" to refine the classification of these lesions.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23887161     DOI: 10.1097/PAS.0b013e31829723e7

Source DB:  PubMed          Journal:  Am J Surg Pathol        ISSN: 0147-5185            Impact factor:   6.394


  36 in total

1.  TTF-1 expressing sellar neoplasm with ependymal rosettes and oncocytic change: mixed ependymal and oncocytic variant pituicytoma.

Authors:  Zaid Saeed Kamil; Grant Sinson; Hasan Gucer; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-12       Impact factor: 3.943

2.  [The 2017 WHO classification of pituitary tumors].

Authors:  Wolfgang Saeger
Journal:  Pathologe       Date:  2021-04-20       Impact factor: 1.011

Review 3.  [New aspects of tumor pathology of the pituitary].

Authors:  W Saeger
Journal:  Pathologe       Date:  2015-05       Impact factor: 1.011

4.  KIAA1377 is associated with lymph node metastasis in esophageal squamous cell carcinoma.

Authors:  Shu-Tao Zheng; Chen-Chen Yang; Qing Liu; Tao Liu; Mang Lu; Fang Dai; Xiang-Peng Gao; Ilyar Sheyhidin; Xiao-Mei Lu
Journal:  Oncol Lett       Date:  2016-11-02       Impact factor: 2.967

Review 5.  Spindle cell oncocytoma of the pituitary gland.

Authors:  Alexandra M Giantini Larsen; David J Cote; Hasan A Zaidi; Wenya Linda Bi; Paul J Schmitt; J Bryan Iorgulescu; Michael B Miller; Timothy R Smith; M Beatriz Lopes; John A Jane; Edward R Laws
Journal:  J Neurosurg       Date:  2018-10-19       Impact factor: 5.115

6.  Management of pituicytomas: a multicenter series of eight cases.

Authors:  Etienne Lefevre; Schahrazed Bouazza; Franck Bielle; Anne-Laure Boch
Journal:  Pituitary       Date:  2018-10       Impact factor: 4.107

7.  Immunoprofiling of glial tumours of the neurohypophysis suggests a common pituicytic origin of neoplastic cells.

Authors:  Christian Hagel; Rolf Buslei; Michael Buchfelder; Rudolf Fahlbusch; Markus Bergmann; Armin Giese; Jörg Flitsch; Dieter K Lüdecke; Markus Glatzel; Wolfgang Saeger
Journal:  Pituitary       Date:  2017-04       Impact factor: 4.107

Review 8.  Genomics and Epigenomics of Pituitary Tumors: What Do Pathologists Need to Know?

Authors:  Sylvia L Asa; Ozgur Mete; Shereen Ezzat
Journal:  Endocr Pathol       Date:  2021-01-12       Impact factor: 3.943

9.  A history of pituitary pathology.

Authors:  Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2014-03       Impact factor: 3.943

10.  TFE3-Expressing Perivascular Epithelioid Cell Neoplasm (PEComa) of the Sella Turcica.

Authors:  Martin D Hyrcza; Daniel A Winer; Mary Shago; Karolyn Au; Gelareh Zadeh; Sylvia L Asa; Ozgur Mete
Journal:  Endocr Pathol       Date:  2017-03       Impact factor: 3.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.